ChemoMetec A/S (OCSE:CHEMM) Net Income From Continuing Operations : kr180.4 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is ChemoMetec A/S Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. ChemoMetec A/S's net income from continuing operations for the six months ended in Dec. 2023 was kr84.6 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was kr180.4 Mil.

ChemoMetec A/S Net Income From Continuing Operations Historical Data

The historical data trend for ChemoMetec A/S's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec A/S Net Income From Continuing Operations Chart

ChemoMetec A/S Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Income From Continuing Operations

Get a 7-Day Free Trial

54.08

77.47

116.02

202.85

230.56

ChemoMetec A/S Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial															106.25	96.61	134.76	95.80	84.65

ChemoMetec A/S Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr180.4 Mil.

ChemoMetec A/S (OCSE:CHEMM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec A/S (OCSE:CHEMM) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

CHEMMc:UK 0DZ0:UK CHY:Germany

Address

Gydevang 43, Allerod, DNK, 3450

Website

https://www.chemometec.com

ChemoMetec A/S specializes in the design, development, and production of instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing, and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others.

ChemoMetec A/S (OCSE:CHEMM) Headlines

No Headlines